| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.25 | 2e-09 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.28 | 8e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |